Saudi: Avalon Pharma announces IPO final offer price

FAISAL NASSER

The final offer price for the offering has been set at $21.86 per share, implying a market capitalisation of $437.33mln at listing

Staff Writer, TradeArabia

January 25, 2024

PHOTO

Middle East Pharmaceutical Industries Company (Avalon Pharma), one of the fastest growing home-grown pharmaceutical manufacturing companies in Saudi Arabia, has nnounced the completion of the book-building process for participating parties and the final offer price for the company’s initial public offering (IPO).

The final offer price for the offering has been set at SAR82 per share, implying a market capitalisation of SAR1.64 billion ($437.33 million) at listing.

The recorded orders during the institutional book-building stood at around SAR68.27 billion ($18.21 billion), representing a coverage of 138.76 times.

The retail subscription period will last for three days, commencing on January 30 and ending on February 1.

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.